🇺🇸 FDA
Company

Black

Black Diamond Therapeutics

BDTX biotech USA

Quick answer

Black is a biotech company (BDTX) headquartered in CAMBRIDGE, MA, USA with 17 tracked pipeline programs.

Pipeline (17)

project

Active Surveillance

Muscle-Invasive Bladder Carcinoma

Phase 3 · other · active

1 trials project

Placebo

Parkinsons Disease (PD)

Phase 3 · small_molecule · active

1 trials project

PTH

Osteoporosis

Phase 2 · small_molecule · completed

1 trials project

Use autologous cSVF + MSCs (cryo) for management of autoimmune component, anti-inflammatory and immune modulation

Autism Spectrum Disorder

Phase 2 · mab · active

1 trials project

silevertinib (BDTX-1535) monotherapy

Non-Small Cell Lung Cancer

Phase 2 · small_molecule · active

1 trials project

silevertinib in combination with temozolomide

Glioblastoma (GBM)

Phase 2 · small_molecule · active

1 trials project

Azathioprine 50Mg Tab

Therapeutic Equivalency

Phase 1 · small_molecule · completed

1 trials project

BDTX-189

Solid Tumor

Phase 1 · small_molecule · terminated

1 trials project

Levodopa

Parkinson's Disease

Phase 1 · small_molecule · completed

1 trials project

Liberase Enzyme (Roche)

Pulmonary Alveolar Proteinosis

Phase 1 · small_molecule · active

1 trials project

Normal Saline (NS) .9% 10 mL Injection

Ovarian Failure

Phase 1 · small_molecule · active

1 trials project

YF476

Hypergastrinaemia

Phase 1 · small_molecule · completed

2 trials project

Chocolate PTA Balloon

Atherosclerosis

Approved · other · active

1 trials project

Liposomal bupivacaine

Liposomal Bupivacaine

Approved · small_molecule · active

1 trials project

DGB-01 Supplementation

Fatigue

Unknown · other · completed

1 trials project

Percutaneous Transluminal Angioplasty (PTA)

Peripheral Artery Disease

Unknown · other · active

1 trials project

Percutaneous Transluminal Angioplasty (PTA) MagicTouch Sirolimus Coated PTA Balloon Catheter

Peripheral Artery Disease

Unknown · other · active

1 trials

Drugs (1)

drug

cromolyn sodium

CROMOLYN SODIUM

Patents (8)

patent

US 12343394

CD38 modulating antibody agents

Expires Mon Jun 26 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12325699

Antibacterial compounds

Expires Mon Jun 05 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12304964

CD38 modulating antibody

Expires Mon May 15 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12187754

LpxC inhibitors and uses thereof

Expires Mon Jan 02 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12162949

CD38 antibody

Expires Mon Dec 05 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12161717

CD38 modulating antibody agents

Expires Mon Dec 05 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11897873

Kappa opioid receptor antagonists and products and methods related thereto

Expires Mon Feb 08 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11780930

CD38 modulating antibody

Expires Mon Oct 05 2043 00:00:00 GMT+0000 (Coordinated Universal Time)